Method for early prediction of acute and chronic rejection of a transplanted organ by analyzing exosomes specific to transplanted organ in recipient’s biological fluids.
Quantitative RNA, proteomic, and metabolite profiling of islet β cells-specific exosomes in patient plasma/serum as marker for monitoring metabolic diseases, such as type I or type II diabetes, metabolic syndrome, and obesity.